Intermittent Fasting Outperforms Diabetes Drugs In New Study
Intermittent fasting may control blood sugar effectively for Type 2 diabetes compared to standard medications, showing potential for managing diabetes through dietary changes.
Drug that melts away' tumours could replace surgery for bowel cancer, say doctors
Pembrolizumab immunotherapy before surgery boosts bowel cancer cure rates, potentially replacing chemotherapy and surgery.
New cervical cancer treatment regime cuts risk of dying from disease by 40%'
New treatment for cervical cancer reduces risk of dying by 40%, marking a significant breakthrough in the last 25 years of medical research.
The first personalized mRNA cancer vaccine for melanoma reduces risk significantly, showing promising results for cancer treatment.
Natural killer cells show their cancer-fighting worth
Natural killer (NK) cells from umbilical-cord blood show promise as a potentially effective and less side-effect-prone alternative to T-cell therapies for blood cancer treatment.
A non-chemotherapy treatment regimen called ViPOR is achieving full remissions for some patients with aggressive B-cell lymphoma. Combination targets multiple molecular pathways crucial for tumor survival.
Intermittent Fasting Outperforms Diabetes Drugs In New Study
Intermittent fasting may control blood sugar effectively for Type 2 diabetes compared to standard medications, showing potential for managing diabetes through dietary changes.
Drug that melts away' tumours could replace surgery for bowel cancer, say doctors
Pembrolizumab immunotherapy before surgery boosts bowel cancer cure rates, potentially replacing chemotherapy and surgery.
New cervical cancer treatment regime cuts risk of dying from disease by 40%'
New treatment for cervical cancer reduces risk of dying by 40%, marking a significant breakthrough in the last 25 years of medical research.
The first personalized mRNA cancer vaccine for melanoma reduces risk significantly, showing promising results for cancer treatment.
Natural killer cells show their cancer-fighting worth
Natural killer (NK) cells from umbilical-cord blood show promise as a potentially effective and less side-effect-prone alternative to T-cell therapies for blood cancer treatment.
A non-chemotherapy treatment regimen called ViPOR is achieving full remissions for some patients with aggressive B-cell lymphoma. Combination targets multiple molecular pathways crucial for tumor survival.
The First Crispr Medicine Is Now Approved in the US
Casgevy uses Crispr technology to modify patients' cells and produce healthy hemoglobin.
Casgevy has shown promising results in a clinical trial, with 29 out of 31 patients being free of pain crises for at least a year.
Novel Brain Implant May Give Cognitive Boost For Common Brain Injury
Advancements in brain implants are providing therapeutic answers for patients with traumatic brain injuries.
A small clinical trial showed that deep-brain stimulation with implanted electrodes led to cognitive improvement in individuals with brain injuries.
Afternoon Briefing: Woman with early-onset Alzheimer's gene joins drug trial at Park Ridge hospital
Developers of the Old Post Office faced challenges, including the need for running water.
Heather Mejia enrolled in a clinical trial for early onset Alzheimer's disease.
A fossil skeleton, known as Sue, was discovered on a property in South Dakota and sold for $7.6 million.
Defying fate, woman with early-onset Alzheimer's gene joins new drug trial at Park Ridge hospital
Heather Mejia carried a rare genetic mutation for Dominantly Inherited Alzheimer's Disease and chose to participate in a clinical trial to study potential treatments for the disease.
Dominantly Inherited Alzheimer's Disease affects fewer than 1% of people with Alzheimer's and those with a family history have a 50% chance of inheriting the mutation.
The clinical trial at Advocate Lutheran General Hospital aims to delay the onset of symptoms for Dominantly Inherited Alzheimer's Disease.
Vitamin D recommended levels should be 10x higher: new report
Vitamin D is critical for our health, including bone and teeth health, inflammation regulation, and immune system support.
The current US recommended dietary allowance of vitamin D may be too low, especially for people with heart problems.
Preliminary results from an ongoing clinical trial suggest that many people need significant levels of vitamin D supplements to reach optimal levels for heart health.
The CRISPR Era Is Here
Gene-editing technology CRISPR has successfully treated a patient with sickle-cell disease, providing hope for future treatments.
The treatment resulted in the patient living virtually symptom-free, with 29 out of 30 eligible patients experiencing zero pain crises after treatment.